Alectinib in ALK -positive, crizotinib-resistant, non-small-cell lung cancer: a single-group, multicentre, phase 2 trial
Shaw, Alice T, Dr, Gandhi, Leena, MD, Gadgeel, Shirish, Prof, Riely, Gregory J, MD, Cetnar, Jeremy, MD, West, Howard, MD, Camidge, D Ross, MD, Socinski, Mark A, Prof, Chiappori, Alberto, MD, Mekhail, Tarek, MD, Chao, Bo H, MD, Borghaei, Hossein, DO, Gold, Kathryn A, MD, Zeaiter, Ali, MD, Bordogna, Walter, PhD, Balas, Bogdana, MD, Puig, Oscar, PhD, Henschel, Volkmar, PhD, Ou, Sai-Hong Ignatius, Prof
Published in The lancet oncology (01.02.2016)
Published in The lancet oncology (01.02.2016)
Get full text
Journal Article
Phase 2 Trial of Nivolumab and Ramucirumab for Relapsed Mesothelioma: HCRN-LUN15-299
Dudek, Arkadiusz Z., Xi, Min X., Scilla, Katherine A., Mamdani, Hirva, Creelan, Benjamin C., Saltos, Andreas, Tanvetyanon, Tawee, Chiappori, Alberto
Published in JTO clinical and research reports (01.12.2023)
Published in JTO clinical and research reports (01.12.2023)
Get full text
Journal Article
Safety and activity of alectinib against systemic disease and brain metastases in patients with crizotinib-resistant ALK -rearranged non-small-cell lung cancer (AF-002JG): results from the dose-finding portion of a phase 1/2 study
Gadgeel, Shirish M, MD, Gandhi, Leena, MD, Riely, Gregory J, MD, Chiappori, Alberto A, MD, West, Howard L, MD, Azada, Michele C, MPH, Morcos, Peter N, PharmD, Lee, Ruey-Min, MD, Garcia, Linta, PharmD, Yu, Li, PhD, Boisserie, Frederic, MSc, Di Laurenzio, Laura, PhD, Golding, Sophie, MSc, Sato, Jotaro, MS, Yokoyama, Shumpei, MS, Tanaka, Tomohiro, MS, Ou, Sai-Hong Ignatius, Dr
Published in The lancet oncology (01.09.2014)
Published in The lancet oncology (01.09.2014)
Get full text
Journal Article
Phase 2 Study of Concurrent Cetuximab Plus Definitive Thoracic Radiation Therapy Followed by Consolidation Docetaxel Plus Cetuximab in Poor Prognosis or Elderly Patients With Locally Advanced Non-Small Cell Lung Cancer
Dilling, Thomas J., MD, Extermann, Martine, MD, Kim, Jongphil, PhD, Thompson, Lora M., PhD, Yue, Binglin, MS, Stevens, Craig W., MD, PhD, Antonia, Scott, MD, Gray, Jhanelle, MD, Williams, Charles, MD, Haura, Eric, MD, Pinder-Schenck, Mary, MD, Tanvetyanon, Tawee, MD, Kim, Sungjune, MD, PhD, Chiappori, Alberto, MD
Published in International journal of radiation oncology, biology, physics (15.11.2014)
Published in International journal of radiation oncology, biology, physics (15.11.2014)
Get full text
Journal Article
Unveiling the Molecular Features of SCLC With a Clinical RNA Expression Panel
Ozakinci, Hilal, Alontaga, Aileen Y., Cano, Pedro, Koomen, John M., Perez, Bradford A., Beg, Amer A., Chiappori, Alberto A., Haura, Eric B., Boyle, Theresa A.
Published in JTO clinical and research reports (01.11.2024)
Published in JTO clinical and research reports (01.11.2024)
Get full text
Journal Article
Phase 2 Study of Erlotinib in Combination with Linsitinib (OSI-906) or Placebo in Chemotherapy-naive Patients with Non–Small-Cell Lung Cancer and Activating Epidermal Growth Factor Receptor Mutations
Leighl, Natasha B., MD, Rizvi, Naiyer A., MD, de Lima Lopes, Gilberto, MD, MBA, FAMS, Rudin, Charles M., MD, PhD, Chiappori, Alberto A., MD, Ahn, Myung-Ju, MD, PhD, Chow, Laura QM., MD, Bazhenova, Lyudmila, MD, Dechaphunkul, Arunee, MD, Sunpaweravong, Patrapim, MD, Eaton, Keith, MD, PhD, Chen, Jihong, PhD, Medley, Sonja, MPH, Poondru, Srinivasu, PhD, Singh, Margaret, PharmD, Steinberg, Joyce, MD, Juergens, Rosalyn A., MD, PhD, Gadgeel, Shirish M., MD
Published in Clinical lung cancer (01.01.2017)
Published in Clinical lung cancer (01.01.2017)
Get full text
Journal Article